Risk of Intracranial Hemorrhage in Users of Oral Antithrombotic Drugs
Status:
Completed
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
The true incidence and risks of intracranial hemorrhage (ICH) in patients on various
antithrombotic treatments remain unknown. Here a nationwide study is conducted to investigate
the risk for and incidence rates of ICH in users and non-users of various oral antithrombotic
drugs in Norway between 2008 through 2014.
Hopefully, this study will contribute to a more responsible prescription pattern of
antithrombotic medications.